A PYMNTS Company

US: Takeda loses bid to DQ Baker Botts in antitrust case

By  |  June 9, 2019

Takeda Pharmaceutical Company on Thursday, June 6, lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals in a lawsuit accusing Takeda of an antitrust violation.

Affirming a magistrate judge, US District Judge Freda Wolfson in Trenton, New Jersey, rejected Takeda’s argument that it had an implied attorney-client relationship with Baker Botts because of the firm’s previous representation of Takeda’s co-plaintiff in related patent litigation.

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.